Literature DB >> 20383005

X-ray structure and characterization of carbamate kinase from the human parasite Giardia lamblia.

Andrey Galkin1, Liudmila Kulakova, Rui Wu, Theodore E Nash, Debra Dunaway-Mariano, Osnat Herzberg.   

Abstract

Carbamate kinase catalyzes the reversible conversion of carbamoyl phosphate and ADP to ATP and ammonium carbamate, which is hydrolyzed to ammonia and carbonate. The three-dimensional structure of carbamate kinase from the human parasite Giardia lamblia (glCK) has been determined at 3 A resolution. The crystals belonged to the monoclinic space group P2(1), with unit-cell parameters a = 69.77, b = 85.41, c = 102.1 A, beta = 106.8 degrees . The structure was refined to a final R factor of 0.227. The essentiality of glCK together with its absence in humans makes the enzyme an attractive candidate for anti-Giardia drug development. Steady-state kinetic rate constants have been determined. The k(cat) for ATP formation is 319 +/- 9 s(-1). The K(m) values for carbamoyl phosphate and ADP are 85 +/- 6 and 70 +/- 5 microM, respectively. The structure suggests that three invariant lysine residues (Lys131, Lys216 and Lys278) may be involved in the binding of substrates and phosphoryl transfer. The structure of glCK reveals that a glycerol molecule binds in the likely carbamoyl phosphate-binding site.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383005      PMCID: PMC2852327          DOI: 10.1107/S1744309110004665

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  25 in total

Review 1.  The rest is silence.

Authors:  E Bernstein; A M Denli; G J Hannon
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

2.  Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli.

Authors:  Sreedevi Nallamsetty; Brian P Austin; Kerri J Penrose; David S Waugh
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

3.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

4.  Cloning and expression of a prokaryotic enzyme, arginine deiminase, from a primitive eukaryote Giardia intestinalis.

Authors:  L A Knodler; E O Sekyere; T S Stewart; P J Schofield; M R Edwards
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

5.  The carbamate kinase-like carbamoyl phosphate synthetase of the hyperthermophilic archaeon Pyrococcus furiosus, a missing link in the evolution of carbamoyl phosphate biosynthesis.

Authors:  V Durbecq; C Legrain; M Roovers; A Piérard; N Glansdorff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Mass cultivation of Giardia lamblia in a serum-free medium.

Authors:  S C Wieder; D B Keister; D S Reiner
Journal:  J Parasitol       Date:  1983-12       Impact factor: 1.276

7.  Bacterial-like energy metabolism in the amitochondriate protozoon Hexamita inflata.

Authors:  Giancarlo A Biagini; Nigel Yarlett; Graham E Ball; Ann C Billetz; Donald G Lindmark; Martha P Martinez; David Lloyd; Michael R Edwards
Journal:  Mol Biochem Parasitol       Date:  2003-04-25       Impact factor: 1.759

8.  The 1.5 A resolution crystal structure of the carbamate kinase-like carbamoyl phosphate synthetase from the hyperthermophilic Archaeon pyrococcus furiosus, bound to ADP, confirms that this thermostable enzyme is a carbamate kinase, and provides insight into substrate binding and stability in carbamate kinases.

Authors:  S Ramón-Maiques; A Marina; M Uriarte; I Fita; V Rubio
Journal:  J Mol Biol       Date:  2000-06-02       Impact factor: 5.469

9.  Mechanisms of catalysis and inhibition operative in the arginine deiminase from the human pathogen Giardia lamblia.

Authors:  Zhimin Li; Liudmila Kulakova; Ling Li; Andrey Galkin; Zhiming Zhao; Theodore E Nash; Patrick S Mariano; Osnat Herzberg; Debra Dunaway-Mariano
Journal:  Bioorg Chem       Date:  2009-06-13       Impact factor: 5.275

10.  The pathway of arginine catabolism in Giardia intestinalis.

Authors:  P J Schofield; M R Edwards; J Matthews; J R Wilson
Journal:  Mol Biochem Parasitol       Date:  1992-03       Impact factor: 1.759

View more
  6 in total

1.  Structural basis for inactivation of Giardia lamblia carbamate kinase by disulfiram.

Authors:  Andrey Galkin; Liudmila Kulakova; Kap Lim; Catherine Z Chen; Wei Zheng; Illarion V Turko; Osnat Herzberg
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

2.  Enzymology of the pathway for ATP production by arginine breakdown.

Authors:  Tjeerd Pols; Shubham Singh; Cecile Deelman-Driessen; Bauke F Gaastra; Bert Poolman
Journal:  FEBS J       Date:  2020-05-05       Impact factor: 5.542

3.  Structural characterization of the enzymes composing the arginine deiminase pathway in Mycoplasma penetrans.

Authors:  Pablo Gallego; Raquel Planell; Jordi Benach; Enrique Querol; Josep A Perez-Pons; David Reverter
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

4.  A homogenous luminescence assay reveals novel inhibitors for giardia lamblia carbamate kinase.

Authors:  Catherine Z Chen; Noel Southall; Andrey Galkin; Kap Lim; Juan J Marugan; Liudmila Kulakova; Paul Shinn; Danielle van Leer; Wei Zheng; Osnat Herzberg
Journal:  Curr Chem Genomics       Date:  2012-12-31

5.  Crystal structures of carbamate kinase from Giardia lamblia bound with citric acid and AMP-PNP.

Authors:  Kap Lim; Liudmila Kulakova; Andrey Galkin; Osnat Herzberg
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

6.  Discovery and Preclinical Development of Antigiardiasis Fumagillol Derivatives.

Authors:  Janak Padia; Liudmila Kulakova; Andrey Galkin; Osnat Herzberg
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.